Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 5—May 2003
Research

Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario Analysis

Marianne L.L. van Genugten*Comments to Author , Marie-Louise A. Heijnen*, and Johannes C. Jager*
Author affiliations: *National Institute for Public Health and the Environment, Bilthoven, the Netherlands

Main Article

Table 7

Hospitalizations and deaths for alternative influenza vaccine efficacya

Scenario No. of hospitalizations
No. of deaths
Base case Vaccine efficacy
Base case Vaccine efficacy
All age groups equal to 80%b Age groups <64 y = 40%; for >65 = 30%c All age groups equal to 80% Age groups <64 y = 40%; for >65 y = 30%c
Nonintervention
10,186
10,186
10,186
4,040
4,040
4,040
Influenza vaccination






Total population
3,847
2,037
6,866
1,738
808
2,811
Risk groups 3,968 2,158 6,926 1,789 859 2,837

aSee Table 1.
bMinimum variant based on Meltzer et al. (9).
cMaximum variant assumes 80% efficacy for all ages.

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external